The Biosimilars Forum Congratulates Robert Califf on His Nomination for FDA Commissioner

Juliana Reed, President the Biosimilars Forum, released the following statement in support of President Biden’s nomination of Dr. Robert Califf to serve as commissioner of the U.S. Food & Drug Administration (FDA):

“The members of the Biosimilars Forum and I congratulate Dr. Califf on his nomination to be the next commissioner of the FDA, and we look forward to working with the new commissioner and the civil servants at FDA to support its mission to protect and promote public health.

“The Biosimilars Forum’s top priority is to work with Congress and the FDA to serve as a voice for patients and to advocate for commonsense policy solutions that give more patients access to life-saving, lower-cost biosimilars.

“Biosimilars are critical to lowering drug prices for all Americans. We look forward to continuing our work with the Biden Administration, Congress and the new FDA commissioner to provide safe and effective lower-cost biosimilars to Americans that need them.”

For more information on the Biosimilars Forum’s work to increase access to lower-cost biosimilars, visit